Sameer Ralhan - 01 Mar 2023 Form 4/A - Amendment Insider Report for Chemours Co (CC)

Reporting relationship: SVP, CFO
Issuer ticker: CC
Reported as of: 01 Mar 2023
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 10 Mar 2023, 12:50:38 UTC
Original report date: 03 Mar 2023
Prior SEC filing: 14 Feb 2023
Next SEC filing: 02 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Pauletta Brown, Attorney-in-Fact

Key filing fact

Sameer Ralhan filed Form 4/A - Amendment for Chemours Co (CC) on 10 Mar 2023.

Key facts

This page summarizes Sameer Ralhan's Form 4/A - Amendment filing for Chemours Co (CC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Mar 2023, 12:50.

Change

Previous filing in this sequence was filed on 14 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CC transaction Derivative

Performance Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +28,807
Change %
Price: $0.000000
Shares after: 28,807
Date: 01 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,807
Exercise price: $38.32
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

Footnote F2

The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

Footnote F3

These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.